Covid 19 EUA

The FDA is working to develop and approve safe and effective therapeutic COVID-19 treatments.  The FDA established CTAP, the Coronavirus Treatment Acceleration Program, to expedite the development of COVID-19 treatments.  A handful of treatments including Convalescent Plasma have been approved for emergency use authorization (EUA), but only one, Remdesivir, is approved for treatment. 

Choose a treatment, Convalescent Plasma or Remdesivir, research it and provide a summary of  the treatment.
Is it effective?  Based on your findings discuss your thoughts about its use, safety, and effectiveness thus far.